共 50 条
- [1] PREVENTION OF CYTOMEGALOVIRUS DISEASE IN TRANSPLANT RECIPIENTSNEW ZEALAND MEDICAL JOURNAL, 1993, 106 (967) : 468 - 469PIDGEON, GBBAILEY, RR
- [2] PREVENTION OF CYTOMEGALOVIRUS DISEASE IN TRANSPLANT RECIPIENTSLANCET, 1995, 346 (8987): : 1380 - 1381WINSTON, DJ
- [4] CYTOMEGALOVIRUS DISEASE IN TRANSPLANT RECIPIENTSNEW ZEALAND MEDICAL JOURNAL, 1994, 107 (970) : 18 - 18FAOAGALI, JL
- [5] Rationale use of valganciclovir for the prevention of cytomegalovirus disease in renal transplant recipientsAMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 494 - 495Gabardi, SMagee, CCBaroletti, SAPowelson, JChandraker, AK
- [6] Preemptive treatment for the prevention of cytomegalovirus disease - In lung and heart transplant recipientsTRANSPLANTATION, 1998, 65 (05) : 747 - 752Egan, JJLomax, JBarber, LLok, SSMartyszczuk, RYonan, NFox, ADeiraniya, AKTurner, AJWoodcock, AA
- [7] Oral ganciclovir monotherapy in the prevention of cytomegalovirus disease in liver transplant recipientsGASTROENTEROLOGY, 1999, 116 (04) : A715 - A715Firpi, RJBhardwaj, GNelson, DRSoldevila, CReed, ADavis, GL
- [8] PREVENTION AND TREATMENT OF CYTOMEGALOVIRUS PNEUMONIA IN TRANSPLANT RECIPIENTSCLINICAL INFECTIOUS DISEASES, 1993, 17 : S392 - S399ZAIA, JA
- [9] Ganciclovir - An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipientsDRUGS, 2001, 61 (08) : 1153 - 1183McGavin, JKGoa, KL